Related Experiment Videos
Suicide prevention and serotonergic drugs
1Academic Department of Psychiatry, St Mary's Hospital Medical School, London, UK.
International Clinical Psychopharmacology
|November 1, 1993
Summary
Not all antidepressants equally reduce suicidal ideation. Serotonin reuptake inhibitors show a protective effect against suicidal thoughts and do not provoke suicide attempts, unlike some other antidepressants.
Area of Science:
- Pharmacology
- Psychiatry
- Clinical Medicine
Background:
- Antidepressants are often assumed to universally reduce suicidal ideation.
- Evidence suggests variability in antidepressant efficacy and potential for some to provoke suicidal behavior.
Purpose of the Study:
- To evaluate the differential effects of antidepressants on suicidal ideation and behavior.
- To investigate whether serotonin reuptake inhibitors (SSRIs) provoke suicide attempts.
Main Methods:
- Review of existing studies on antidepressant effects on suicidal ideation and attempts.
- Analysis of data comparing maprotiline and placebo for suicide attempts.
- Examination of overdose death rates with tricyclic antidepressants.
- Assessment of SSRI effects on suicidal ideation and direct testing on suicidal behavior.
Main Results:
- Some antidepressants show better efficacy in reducing suicidal ideation than others.
- Tricyclic antidepressants have been associated with higher rates of overdose deaths.
- Serotonin reuptake inhibitors consistently reduce suicidal ideation and prevent suicidal thoughts.
- Direct studies indicate SSRIs do not provoke suicide attempts.
Conclusions:
- Antidepressant effects on suicidal ideation and behavior are not uniform.
- Serotonin reuptake inhibitors appear safer regarding suicidal behavior compared to some other classes.
- Further research is needed to fully understand antidepressant-induced suicidal behavior.